Scientists working with the Scripps Research Institute say they have solved the problem of stem cell fragility, a major hurdle that has long-hindered the progress of stem cell research.
During the culture process, stem cells frequently die unless scientists take very meticulous, labor-intensive steps to keep them alive. By introducing two compounds called Thiazovivin and Pyrintegrin, the cells are protected, increasing their survival rate significantly.
Developments in stem cell research, though a subject of debate, offer hope for revolutionary therapeutic purposes, including treatment of injuries, diabetes, Parkinson’s disease, and aging. The regenerative properties of pluripotent stem cells could facilitate tissue repair in a variety of applications – even cosmetic treatments.
Read more about these findings from the Scripps Research Institute
